Skip to content
Case File
d-27189House OversightOther

Ackrell Capital Cannabis Industry Segmentation Report – Concentrates Sales and Extraction Methods (Q3 2017)

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024683
Pages
1
Persons
2

Summary

The passage provides market data on cannabis concentrate sales and technical details on extraction methods. It contains no references to high‑profile individuals, government agencies, financial flows, Q3 2017 concentrate sales split: Live resin (6%), B Oils (18%), Shatter (16%), Vape oil (17%), Wax ( Two extraction categories: solvent‑based (hydrocarbon, CO₂, ethanol) and solvent‑free (filters, ic

This document is from the House Oversight Committee Releases.

View Source Collection

Persons Referenced (2)

Tags

cannabis-industryregulationmarket-dataconcentratesindustry-analysisextraction-methodshouse-oversightregulatory-compliance
Share
PostReddit

Related Documents (6)

House OversightOtherNov 11, 2025

Directory of Private Cannabis Companies Featured in House Oversight Report

The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti

1p
House OversightOtherNov 11, 2025

Ackrell Capital Cannabis OTC Market Valuation Table (2017)

The document is a financial listing of small OTC cannabis companies with market metrics. It contains no references to influential political figures, government agencies, or alleged misconduct, offerin Provides EV multiples and stock price discounts for over 40 cannabis firms. Compiled by Ackrell Capital, a FINRA/SIPC member. Data dated November 30, 2017.

1p
House OversightOtherNov 11, 2025

List of Private Cannabis Companies from 2018 Report

The document is merely a catalog of cannabis industry firms without any allegations, transactions, dates, or connections to high‑profile individuals or agencies. It offers no actionable investigative Compilation of over 100 private cannabis companies from a 2018 report Includes brand names, labs, dispensaries, and investment entities No mention of government officials, financial flows, or miscond

1p
House OversightOtherNov 11, 2025

Cannabis Investment Report – December 2017 Financial Metrics

The document is a financial summary of cannabis‑related public companies with valuation multiples and revenue figures. It contains no references to political figures, government agencies, foreign lead Provides LTM and forward revenue, EBITDA, and enterprise value for several cannabis firms. Lists stock tickers and market percentages for each company. Notes methodology for handling negative or extr

1p
House OversightOtherNov 11, 2025

Ackrell Capital report shows modest capital raised by U.S. publicly traded cannabis companies in 2017

The passage provides only aggregate financial data on small, largely unprofitable cannabis firms with no mention of high‑profile individuals, government agencies, or illicit activity. It lacks specifi Only $268 million total equity and debt raised by listed cannabis firms in the 12‑month period endin Most companies had little to no revenue and were not profitable. A single large $317 million finan

1p
House OversightOtherNov 11, 2025

Ackrell Capital Cannabis Company Financial Metrics Table

The document is a plain financial summary of cannabis companies listed on the Canadian Securities Exchange with no mention of influential actors, misconduct, or controversial transactions. It offers n Provides market cap, revenue, EBITDA, and valuation multiples for dozens of cannabis firms. Includes percentages of stock price below enterprise value. No names of political figures, government agenc

1p

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.